Interstitial Lung Disease (ILD) Treatment
Interstitial Lung Disease (ILD) is a group of disorders that cause inflammation and scarring (fibrosis) of the lung tissue, leading to breathlessness, dry cough, fatigue, and reduced oxygen levels. Early diagnosis and timely management are crucial to slow disease progression and improve quality of life.
Dr. Pankaj Gujar provides comprehensive, patient-centric care for ILD, using a structured diagnostic approach that includes detailed clinical evaluation, pulmonary function tests, high-resolution CT (HRCT) chest imaging, and relevant laboratory investigations. Treatment is tailored to the type and severity of ILD and may include anti-fibrotic medications, corticosteroids, immunosuppressive therapy, oxygen support, and pulmonary rehabilitation.
Dr. Gujar emphasizes regular monitoring, lifestyle guidance, vaccination advice, and multidisciplinary coordination when needed. With evidence-based protocols and compassionate care, the goal is to control symptoms, preserve lung function, reduce exacerbations, and help patients lead a better, more active life.
